| [1] |
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome[J]. Lancet, 2021, 397(10280): 1214-1228.
|
| [2] |
靳梅, 刘静, 刘康, 等. 儿童吉兰-巴雷综合征脑脊液神经丝蛋白轻链特点分析[J]. 临床儿科杂志, 2024, 42(1): 58-62.
|
|
Jin M, Liu J, Liu K, et al. Characteristics of neurofilament light chain levels in cerebrospinal fluid of Guillain-Barre syndrome in children[J]. Linchuang Erke Zazhi, 2024, 42(1): 58-62.
|
| [3] |
Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: an update[J]. Clin Auton Res, 2019, 29(3): 289-299.
|
| [4] |
Chakraborty T, Kramer CL, Wijdicks EFM, et al. Dysautonomia in Guillain-Barré syndrome: prevalence, clinical spectrum, and outcomes[J]. Neurocrit Care, 2020, 32(1): 113-120.
|
| [5] |
Bazán-Rodríguez L, Ruiz-Avalos JA, de Saráchaga AJ, et al. Dysautonomia and related outcomes in Guillain-Barre syndrome[J]. Auton Neurosci, 2023, 245: 103070.
|
| [6] |
Nakane S, Koike H, Hayashi T, et al. Autoimmune autonomic neuropathy: from pathogenesis to diagnosis[J]. Int J Mol Sci, 2024, 25(4): 2296.
|
| [7] |
Gupta S, Verma R, Sethi R, et al. Cardiovascular complications and its relationship with functional outcomes in Guillain-Barré syndrome[J]. QJM, 2020, 113(2): 93-99.
|
| [8] |
Ishaque T, Islam MB, Ara G, et al. High mortality from Guillain-Barré syndrome in Bangladesh[J]. J Peripher Nerv Syst, 2017, 22(2): 121-126.
|
| [9] |
中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组. 中国吉兰-巴雷综合征诊治指南2024[J]. 中华神经科杂志, 2024, 57(9): 936-944.
|
|
Chinese Society of Neurology, Peripheral Neuropathy Collaboration Group of Chinese Society of Neurology. Chinese guideline on diagnosis and treatment of Guillain-Barré syndrome 2024[J]. Zhonghua Shenjingke Zazhi, 2024, 57(9): 936-944.
|
| [10] |
Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial prednisolone in acute polyneuropathy[J]. Lancet, 1978, 2(8093): 750-753.
|
| [11] |
van Koningsveld R, Steyerberg EW, Hughes RAC, et al. A clinical prognostic scoring system for Guillain-Barré syndrome[J]. Lancet Neurol, 2007, 6(7): 589-594.
|
| [12] |
Flachenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis[J]. J Neurol, 2007, 254 Suppl 2: II96-II101.
|
| [13] |
Burns TM, Lawn ND, Low PA, et al. Adynamic ileus in severe Guillain-Barré syndrome[J]. Muscle Nerve, 2001, 24(7): 963-965.
|
| [14] |
Arsenijevic M, Berisavac I, Bozovic I, et al. Self-reported autonomic dysfunction in a recovery phase of Guillain-Barré syndrome[J]. Clin Neurol Neurosurg, 2021, 201: 106427.
|
| [15] |
Asahina M, Kuwabara S, Suzuki A, et al. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome[J]. Acta Neurol Scand, 2002, 105(1): 44-50.
|
| [16] |
Sakakibara R, Uchiyama T, Kuwabara S, et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barré syndrome[J]. Neurourol Urodyn, 2009, 28(5): 432-437.
|
| [17] |
Bellanti R, Rinaldi S. Guillain-Barré syndrome: a comprehensive review[J]. Eur J Neurol, 2024, 31(8): e16365.
|
| [18] |
Mahajan R, Kalita J, Jha V, et al. Temporal pattern of individual neurological function recovery in Guillain-Barré syndrome[J]. J Clin Med, 2024, 13(18): 5635.
|
| [19] |
Ryan MM. Pediatric Guillain-Barré syndrome[J]. Curr Opin Pediatr, 2013, 25(6): 689-693.
|